- Posted
- Categories
-
- OpenSAFELY
OpenSAFELY Symposium 2024: there's still time to sign up
It’s not too late to register for our 2nd Annual OpenSAFELY Symposium, which is happening in London on 25/26 November.
Blog
Latest news and views from around the Bennett Institute
-
-
- Posted
- Categories
-
- OpenPrescribing
Changes to Direct Oral Anticoagulant (DOAC) measure
We’ve updated the DOAC measure following changes to the NHS England commissioning guidance.
-
- Posted
- Categories
-
- OpenPrescribing
Exciting new developments with hospital medicines data
We briefly summarise all the recent big and exciting developments in hospital medicines data.
-
- Posted
- Categories
-
- OpenSAFELY
OpenSAFELY for retail data? Every little helps
Someone on the radio was musing about using retail data for health - we have some thoughts on that.
-
- Posted
Come along to our guest lectures by George Davey Smith
George is visiting the Bennett Institute on 30 September, to give two guest lectures
-
- Posted
- Categories
-
- OpenSAFELY
Recent paper outputs from the OpenSAFELY Community
In the past 6 months we’ve been very productive at OpenSAFELY publishing 21 peer-reviewed papers on a variety of topics.
-
- Posted
- Categories
-
- OpenSAFELY
The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19
In this guest blog, Katie Bechman describes the proof-of-principle pharmacovigilance study she conducted with the help of her team from King’s College London, which used OpenSAFELY to examine the safety of sotrovimab, paxlovid and molnupiravir in prehospital treatment of Covid-19.
-
- Posted
- Categories
-
- OpenPrescribing
Openprescribing Summer 2024 Newsletter
This newsletter contains all the latest updates from OpenPrescribing
-
- Posted
- Categories
-
- OpenPrescribing
Changes to how we estimate the financial impact of Price Concessions on the NHS
We’ve been producing estimates on the impact of Price Concessions since 2017. In this blog we describe the changes we’re making in how we estimate the costs.
-
- Posted
- Categories
-
- OpenPrescribing
Sign up for our free OpenPrescribing webinars
We’re setting up webinars for different groups to show how to use OpenPrescribing effectively. Each session will cover the basics and tips for getting the most out of it.
-
- Posted
- Categories
-
- OpenSAFELY
Join us for our 2nd Annual OpenSAFELY Community Symposium!
Two days of talks and workshops on research, data infrastructure, and open science.
-
- Posted
- Categories
-
- OpenPrescribing
You can't always get what you want - why medicines don't always show up on OpenPrescribing
We describe the reasons why people sometimes find a medicine on OpenPrescribing.
-
- Posted
- Categories
-
- Team
Sometimes, the work is getting to know the people you work with
Notes from the Bennett Institue Team Retreat.
-
- Posted
- Categories
-
- OpenSAFELY
Recording technical decisions using ADRs
The Research Experience team explain how they’ve been recording decisions
-
- Posted
- Categories
-
- OpenSAFELY
We won an MRC award for open science
Most of the time, we like to keep things fairly formal on this blog - but if you’ll forgive us a small indulgence, today we’re going to blow our own trumpet a little. A couple of weeks ago, my colleague Rose Higgins and I went to an event in London where this Institute was awarded the Open Science Impact award, as part of the MRC Impact Prize. We were, needless to say, over the moon about it.
-
- Posted
- Categories
-
- OpenSAFELY
Research-ready computers in the cloud
Spend more time answering your research questions – and less time wrangling your computer – with GitHub Codespaces and the OpenSAFELY development container.
-
- Posted
- Categories
-
- OpenSAFELY
How COVID-19 affected sickness absences in England
Our new study looks at the rate that sick notes were issued for people with COVID-19, and how it changed over the course of the pandemic.
-
- Posted
- Categories
-
- OpenSAFELY
No increase to opioid prescribing during the COVID-19 pandemic in England
During the COVID-19 pandemic, there were no sustained increases in opioid prescribing.